D.A. Reaveley

2.5k total citations
33 papers, 1.9k citations indexed

About

D.A. Reaveley is a scholar working on Surgery, Molecular Biology and Nephrology. According to data from OpenAlex, D.A. Reaveley has authored 33 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Molecular Biology and 8 papers in Nephrology. Recurrent topics in D.A. Reaveley's work include Lipoproteins and Cardiovascular Health (6 papers), Dialysis and Renal Disease Management (5 papers) and Probiotics and Fermented Foods (4 papers). D.A. Reaveley is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Dialysis and Renal Disease Management (5 papers) and Probiotics and Fermented Foods (4 papers). D.A. Reaveley collaborates with scholars based in United Kingdom, Austria and Tanzania. D.A. Reaveley's co-authors include Mary Seed, Eric Boerwinkle, Gilbert R. Thompson, Susan McCarthy, Fritz Hoppichler, Gerd Utermann, Darrell V. Pavitt, Edwina A. Brown, Francisco Leyva‐Leon and Gerhard Schüler and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

D.A. Reaveley

33 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.A. Reaveley United Kingdom 22 791 498 402 398 368 33 1.9k
W. F. Keane United States 22 428 0.5× 628 1.3× 413 1.0× 449 1.1× 335 0.9× 42 2.2k
Ilona Staprãns United States 28 620 0.8× 181 0.4× 289 0.7× 729 1.8× 395 1.1× 48 2.5k
P. Michielsen Belgium 34 662 0.8× 171 0.3× 256 0.6× 472 1.2× 392 1.1× 219 4.0k
Autar K. Walli Germany 26 831 1.1× 240 0.5× 415 1.0× 517 1.3× 351 1.0× 71 2.6k
S B Rosalki United Kingdom 26 481 0.6× 155 0.3× 274 0.7× 510 1.3× 499 1.4× 99 2.7k
J H Strømme Norway 20 360 0.5× 119 0.2× 283 0.7× 603 1.5× 320 0.9× 49 2.6k
K.K. Talwar India 29 874 1.1× 142 0.3× 1.4k 3.4× 405 1.0× 345 0.9× 190 3.1k
Sing Hiem Yap Netherlands 30 665 0.8× 190 0.4× 112 0.3× 770 1.9× 149 0.4× 106 2.9k
Ivan Rychlík Czechia 27 287 0.4× 1.3k 2.5× 389 1.0× 1.5k 3.6× 632 1.7× 190 3.7k
Michael Holzer Austria 27 637 0.8× 261 0.5× 341 0.8× 500 1.3× 645 1.8× 59 2.3k

Countries citing papers authored by D.A. Reaveley

Since Specialization
Citations

This map shows the geographic impact of D.A. Reaveley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.A. Reaveley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.A. Reaveley more than expected).

Fields of papers citing papers by D.A. Reaveley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.A. Reaveley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.A. Reaveley. The network helps show where D.A. Reaveley may publish in the future.

Co-authorship network of co-authors of D.A. Reaveley

This figure shows the co-authorship network connecting the top 25 collaborators of D.A. Reaveley. A scholar is included among the top collaborators of D.A. Reaveley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.A. Reaveley. D.A. Reaveley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doehner, Wolfram, Margaret M. Tarpey, Darrell V. Pavitt, et al.. (2003). Elevated plasma xanthine oxidase activity in chronic heart failure: Source of increased oxygen radical load and effect of allopurinol in a placebo controlled, double blinded treatment study. Journal of the American College of Cardiology. 41(6). 207–207. 4 indexed citations
2.
Reaveley, D.A., et al.. (2002). Relationship of renal function to homocysteine and lipoprotein(a) levels: The frequency of the combination of both risk factors in chronic renal impairment. American Journal of Kidney Diseases. 40(5). 916–923. 23 indexed citations
3.
Pavitt, Darrell V., et al.. (2002). Assay of serum allantoin in humans by gas chromatography–mass spectrometry. Clinica Chimica Acta. 318(1-2). 63–70. 33 indexed citations
4.
5.
Waddington, Simon N., et al.. (1996). L-arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney International. 49(4). 1090–1096. 45 indexed citations
6.
Sharpstone, D, Carolyn Murray, H. M. Ross, et al.. (1996). Energy balance in asymptomatic HIV infection. AIDS. 10(12). 1377–1384. 30 indexed citations
7.
Franks, Peter, et al.. (1993). Prevalence of intermittent claudication and risk factors for its development in patients on renal replacement therapy. European Journal of Vascular Surgery. 7(5). 523–527. 31 indexed citations
8.
Seed, Mary, et al.. (1993). Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients?. The Lancet. 341(8840). 268–270. 64 indexed citations
9.
Seed, Mary, et al.. (1993). The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover. Atherosclerosis. 101(1). 61–68. 81 indexed citations
10.
Plan, Manuel R., D.A. Reaveley, M O'Donnell, et al.. (1992). Lipid and lipoprotein (a) concentrations in renal ransplant patients. Nephrology Dialysis Transplantation. 7(7). 636–641. 35 indexed citations
11.
Reaveley, D.A., et al.. (1991). Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Critical Care Medicine. 19(12). 1510–1515. 68 indexed citations
12.
Seed, Mary, Fritz Hoppichler, D.A. Reaveley, et al.. (1990). Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial Hypercholesterolemia. New England Journal of Medicine. 322(21). 1494–1499. 484 indexed citations
13.
Seed, Mary, B. O'Connor, & D.A. Reaveley. (1990). Effects of high endogenous oestrogen level on lipoprotein concentration. Atherosclerosis. 85(1). 96–96. 5 indexed citations
14.
Seed, Mary & D.A. Reaveley. (1989). LP(a) in Familial Hypercholesterolaemia — An Association with Coronary Artery Disease. Clinical Science. 76(s20). 53P–53P. 1 indexed citations
15.
Glynn, Michael, J Powell-Tuck, D.A. Reaveley, & Iain M. Murray‐Lyon. (1988). High Lipid Parenteral Nutrition Improves Portasystemic Encephalopathy. Journal of Parenteral and Enteral Nutrition. 12(5). 457–461. 14 indexed citations
16.
Freeman, Leisa J., et al.. (1987). Psychological stress and silent myocardial ischemia. American Heart Journal. 114(3). 477–482. 72 indexed citations
17.
Glynn, Michael, J Powell-Tuck, D.A. Reaveley, & I M Murray-Lyon. (1986). High lipid parenteral feeds raise plasma branched chain amino acid concentrations—A possible therapeutic approach to portasystemic encephalopathy?. Clinical Nutrition. 5(2). 109–112. 3 indexed citations
18.
Burge, R. E., et al.. (1977). Structure of the peptidoglycan of bacterial cell walls. I. Journal of Molecular Biology. 117(4). 927–953. 63 indexed citations
19.
Millward, G. Robert & D.A. Reaveley. (1974). Electron microscope observations on the cell walls of some gram-positive bacteria. Journal of Ultrastructure Research. 46(3). 309–326. 27 indexed citations
20.
Clarke, K., G. W. Gray, & D.A. Reaveley. (1965). ‘Lipid A’ Component from the Cell-walls of Pseudomonas aeruginosa. Nature. 208(5010). 586–587. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. F. Keane Breakdown of academic impact, for papers by Ilona Staprãns Breakdown of academic impact, for papers by P. Michielsen Breakdown of academic impact, for papers by Autar K. Walli Breakdown of academic impact, for papers by S B Rosalki Breakdown of academic impact, for papers by J H Strømme Breakdown of academic impact, for papers by K.K. Talwar Breakdown of academic impact, for papers by Sing Hiem Yap Breakdown of academic impact, for papers by Ivan Rychlík Breakdown of academic impact, for papers by Michael Holzer
Rankless by CCL
2026